Aegerion Pharmaceuticals, Inc.

March 10, 2021

Aegerion developed innovative products for the treatment of severe lipid disorders. Aegerion went public on Nasdaq in 2010.

Latest news

Paratek Pharmaceuticals completes acquisition of Optinose

May 21, 2025

Zimmer Biomet completes acquisition of Paragon 28

April 21, 2025

GT Medical Technologies Raises $37 Million in Series D to Advance the Expansion of GammaTile® in the U.S. for Patients with Operable Brain Tumors

January 16, 2025

icotec Receives FDA Clearance for Spinal Infection Indication with BlackArmor® implants

January 14, 2025

Hologic completes acquisition of Gynesonics

January 6, 2025

OSSIO Raises $27.6 Million to Accelerate Its Commercial Engine as High Demand for Bio-Integrative Fixation Technology Continues

December 2, 2024

Stryker completes acquisition of Vertos Medical

October 1, 2024

eXmoor Pharma Partners with Quell Therapeutics to Develop CAR-Treg Cell Therapies

September 24, 2024

eXmoor Pharma’s GMP cell and gene therapy manufacturing facility receives license from MHRA

August 20, 2024

Providence Medical Technology, Inc. Announces FDA Clearance of CORUS™ Navigation Access System for Use with Medtronic’s StealthStation™ Surgical Navigation in Posterior Spinal Fusion

June 13, 2024

View all

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Others